2f54: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:2f54.gif|left|200px]]
[[Image:2f54.gif|left|200px]]


{{Structure
<!--
|PDB= 2f54 |SIZE=350|CAPTION= <scene name='initialview01'>2f54</scene>, resolution 2.700&Aring;
The line below this paragraph, containing "STRUCTURE_2f54", creates the "Structure Box" on the page.
|SITE=
You may change the PDB parameter (which sets the PDB file loaded into the applet)
|LIGAND=
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY=
or leave the SCENE parameter empty for the default display.
|GENE= HLA-A, HLAA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]), B2M ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
-->
|DOMAIN=
{{STRUCTURE_2f54| PDB=2f54  | SCENE= }}  
|RELATEDENTRY=[[2f53|2F53]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2f54 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2f54 OCA], [http://www.ebi.ac.uk/pdbsum/2f54 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2f54 RCSB]</span>
}}


'''Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity'''
'''Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity'''
Line 32: Line 29:
[[Category: Rizkallah, P J.]]
[[Category: Rizkallah, P J.]]
[[Category: Sami, M.]]
[[Category: Sami, M.]]
[[Category: cdr2]]
[[Category: Cdr2]]
[[Category: high affinity]]
[[Category: High affinity]]
[[Category: ny-eso-1]]
[[Category: Ny-eso-1]]
[[Category: phage display]]
[[Category: Phage display]]
[[Category: t-cell receptor]]
[[Category: T-cell receptor]]
[[Category: wild type sequence]]
[[Category: Wild type sequence]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 03:28:13 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:58:07 2008''

Revision as of 03:28, 4 May 2008

File:2f54.gif

Template:STRUCTURE 2f54

Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity


OverviewOverview

The mammalian alpha/beta T cell receptor (TCR) repertoire plays a pivotal role in adaptive immunity by recognizing short, processed, peptide antigens bound in the context of a highly diverse family of cell-surface major histocompatibility complexes (pMHCs). Despite the extensive TCR-MHC interaction surface, peptide-independent cross-reactivity of native TCRs is generally avoided through cell-mediated selection of molecules with low inherent affinity for MHC. Here we show that, contrary to expectations, the germ line-encoded complementarity determining regions (CDRs) of human TCRs, namely the CDR2s, which appear to contact only the MHC surface and not the bound peptide, can be engineered to yield soluble low nanomolar affinity ligands that retain a surprisingly high degree of specificity for the cognate pMHC target. Structural investigation of one such CDR2 mutant implicates shape complementarity of the mutant CDR2 contact interfaces as being a key determinant of the increased affinity. Our results suggest that manipulation of germ line CDR2 loops may provide a useful route to the production of high-affinity TCRs with therapeutic and diagnostic potential.

DiseaseDisease

Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]

About this StructureAbout this Structure

2F54 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity., Dunn SM, Rizkallah PJ, Baston E, Mahon T, Cameron B, Moysey R, Gao F, Sami M, Boulter J, Li Y, Jakobsen BK, Protein Sci. 2006 Apr;15(4):710-21. PMID:16600963 Page seeded by OCA on Sun May 4 03:28:13 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA